🚀🧬 Forge your future in science at IDIBAPS and the Hospital Clínic of Barcelona! Join our pioneering CAR-T research team and work towards your PhD. We're seeking bright minds eager to advance cancer therapy.

🔗 www.clinicbarcelona.org/uploads/medi...

#CAR-T #MultipleMyeloma #CancerResearch 🧪🔬

Presenten el primer model per predir la resposta a la teràpia amb cèl·lules #CART en #mieloma múltiple

https://s.mtrbio.com/bzqeztfpaf @fdezdelarrea.bsky.social

The ➡️Myeloma, amyloidosis, macroglobulinemia and other gammapathies⬅️ group led by Carlos Férnandez De Larrea studies the mechanisms that cause people with asymptomatic or premalignant monoclonal gammopathies to develop

👉https://s.mtrbio.com/dtaulqwzoa

🆕Avenços en immunoteràpia CAR-T per evitar les recaigudes en mieloma múltiple

Un equip del #CLÍNIC-#IDIBAPS han introduït una modificació a les CAR-T que fa la seva resposta més duradora en models animals i cel·lulars

👉https://s.mtrbio.com/znabknfoyr

🆕Advances made in CAR-T immunotherapy to prevent relapse in multiple myeloma

A team from #CLÍNIC-#IDIBAPS has introduced a modification to a CAR-T that makes it more durable, according to results obtained in animal and cellular models

👉https://s.mtrbio.com/jsaizukynw

#ASH24 with friends and colleagues @hospitalclinic.bsky.social @ash-hematology.bsky.social @idibaps.bsky.social